Top Markets
Coin of the day
Renascience Inc. Renascience Inc.

Renascience Inc.

4889
Classement en actions #21014
Renascience Inc., established in 2000 and based in Tokyo, Japan, is actively... Renascience Inc., established in 2000 and based in Tokyo, Japan, is actively engaged in pioneering and bringing to market pharmaceuticals and medical devices throughout Japan. The company's pipeline includes RS5614, a PAI-1 inhibitor that has reached Phase 3 clinical trials for a wide range of indications such as chronic myeloid leukemia, malignant melanoma, non-small cell lung cancer, novel coronavirus infections, and FGF23-related hypophosphatemic rickets. Another PAI-1 inhibitor, RS5441, is currently in Phase 1 trials for various dermatological conditions. Additionally, RS8001, a water-soluble vitamin, is undergoing Phase 2 clinical development for the treatment of premenstrual syndrome/premenstrual dysphoric mood disorder, autism spectrum disorder, and menopausal disorder. Beyond its pharmaceutical ventures, Renascience is also advancing the RS9001 disposable ultrafine endoscope, alongside developing artificial intelligence-driven medical solutions and comprehensive diagnostic tools.
Prix de l'action
$8.49
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$117.03M
Changement (1 jour)
-4.82%
Changement (1 an)
-45.48%
Pays
JP
Échange Renascience Inc. (4889)

Catégorie

Historique des divisions d’actions pour Renascience Inc. (4889)
L’action Renascience Inc. (symbole : 4889) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 23, 2026.
Une action 4889 achetée avant le Aug 23, 2026 équivaudrait aujourd’hui à 0 actions 4889.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH